Meeting
2020 ASCO Virtual Scientific Program
Stability of rare TP53 co-mutations in AML patients.
Authors
Kenneth Joel Bloom
Clarient Diagnostic Services, Inc., Aliso Viejo, CA
Kenneth Joel Bloom , Adam Idica , Dave Smart , Wendy Allen , Enya Scanlon , Jordan Clark
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Hematologic Malignancies—Leukemia, Myelodysplastic Syndromes, and Allotransplant
Track
Hematologic Malignancies
Sub Track
Acute Leukemia
Citation
J Clin Oncol 38: 2020 (suppl; abstr 7528)
DOI
10.1200/JCO.2020.38.15_suppl.7528
Abstract #
7528
Poster Bd #
301
Abstract Disclosures
Similar Posters
Poster
2021 ASCO Annual Meeting
Molecular annotation of extramedullary acute myeloid leukemia to identify prevalence of targetable mutations.
First Author: Somedeb Ball
Poster
2020 ASCO Virtual Scientific Program
Pre-transplant molecular minimal residual disease (MMRD) is associated with inferior outcomes in patients with acute myeloid leukemia undergoing allogeneic stem cell transplantation.
First Author: Muhammad Husnain
Poster
2023 ASCO Annual Meeting
Clinical and molecular characteristics of patients with AML with an exceptional response to ivosidenib.
First Author: Justin M. Watts
Poster
2022 ASCO Annual Meeting
Mutational landscape and clinical characterization of over 17,000 patients with myeloid malignancies using real-world data.
First Author: Taylor J. Jensen